Search for Clinical Trial Results

Sponsored By

Ovarian Carcinosarcoma - 20 Studies Found

Status Study
Not yet recruiting Study Name: Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26
Condition:
  • Carcinosarcoma, Ovarian
  • Carcinosarcomas Uterine

Date: 2016-12-01
Interventions: Drug: Trabectedin Other Name: Yondelis
Not yet recruiting Study Name: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
Condition:
  • Advanced Ovarian Carcinoma
  • Primary Peritoneal Carcinoma
  • Date: 2007-08-03
    Interventions: Drug: Avastin Initial Treatment:
Not yet recruiting Study Name: Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
Condition:
  • Ovarian Carcinosarcoma
  • Recurrent Fallopian Tube Carcinoma

    • Date: 2009-08-06
    Interventions:
    • Drug: Paclitaxel Given IV
Recruiting Study Name: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Condition:
  • Ovarian Brenner Tumor
  • Ovarian Carcinosarcoma
  • Drug: Gemcitabine Hydrochloride

Completed Study Name: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
Condition:
  • Fallopian Tube Cancer
  • Female Reproductive Cancer
  • Date: 2006-10-18
    Interventions: Drug: ziv-aflibercept Given IV Other Names:
Completed Study Name: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
Condition:
  • Brenner Tumor
  • Fallopian Tube Cancer

  • Date: 2004-06-10
    Interventions:
    • Drug: carboplatin Given intrap
Active, not recruiting Study Name: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
Condition:
  • Cognitive Side Effects of Cancer Therapy
  • Malignant Ovarian Epithelial Tumor
  • Procedure: Cognitive Assessment

Completed Study Name: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
Condition:
  • Fallopian Tube Carcinoma
  • Infectious Disorder
  • Neutropenia Date: 2006-07-13
    Interventions:
    • Procedure: Adjuvant Therapy
    • Drug: Carbopla
Recruiting Study Name: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers
Condition:
  • Cervical Adenosarcoma
  • Cervical Adenosquamous Carcinoma
  • Cer
    Date: 2013-12-19
    Interventions:
    • Biological: Bevacizumab Given

Active, not recruiting Study Name: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
Condition:
  • Adult Hepatocellular Carcinoma
  • Advanced Adult Hepatocellular Carcinoma
  • Biological: Bevacizumab Given

Next >>>